广泛性疼痛与女性TKA术后无临床改善风险增加相关
基于骨关节炎倡议(OAI)队列,391例确认行TKA的患者中315例有术前疼痛/残疾评估,95%完成随访。女性术前广泛性疼痛与TKA术后2年WOMAC疼痛和KOOS疼痛无临床重要改善的风险增加相关,男性因广泛性疼痛例数少结果不确定。术前广泛性疼痛者术后2年更常使用膝关节骨关节炎症状药物。
要点
- 女性术前广泛性疼痛者TKA术后2年WOMAC疼痛无临床重要改善风险RR 2.93(95%CI 1.18-7.30;p=0.02)。
- 女性术前广泛性疼痛者KOOS疼痛无临床重要改善风险RR 3.39(95%CI 1.34-8.59;p=0.02)。
- 术前广泛性疼痛者术后2年更常使用药物(51% vs 32%;均差18.8[95%CI 7.3-30.1];p<0.01)。
核心结论
- 女性TKA术前广泛性疼痛与术后2年膝关节疼痛无临床重要改善风险增加相关。
- 男性因样本中广泛性疼痛例数少,结果不确定。
研究设计与样本
- Osteoarthritis Initiative(OAI)研究参与者自2005年3月至2015年10月每年随访。
- 4796例参与者中391例确认行TKA,315例有术前方案计划访视的疼痛/残疾评估。
- 95%(298例)有所需随访评估,5%(17例)无随访数据。
- 广泛性疼痛基于改良美国风湿病学会标准定义。
主要发现
- 女性术前广泛性疼痛者WOMAC疼痛无临床重要改善13.5% vs 无广泛性疼痛者4.6%(RR 2.93[95%CI 1.18-7.30];p=0.02)。
- 女性术前广泛性疼痛者KOOS疼痛无临床重要改善16.5% vs 4.9%(RR 3.39[95%CI 1.34-8.59];p=0.02)。
- 男性WOMAC疼痛无临床重要改善RR 0.77(95%CI 0.22-2.70;p=0.68),KOOS疼痛RR 1.37(95%CI 0.47-4.00;p=0.57)。
- 男性WOMAC残疾无临床重要改善RR 0.72(95%CI 0.20-2.55;p=0.61),女性RR 1.98(95%CI 0.92-4.26;p=0.08)。
- 术前广泛性疼痛者术后2年大多数天数使用药物至少1个月的比例51%(61/120) vs 无广泛性疼痛者32%(57/178);均差18.8(95%CI 7.3-30.1);p<0.01。
关键数值与推荐
- WOMAC疼痛评分范围0-20,分数越高疼痛越重;临床重要改善定义为WOMAC疼痛下降≥1.5。
- WOMAC残疾评分范围0-68,分数越高残疾越重;临床重要改善定义为WOMAC残疾下降≥6.0。
- KOOS疼痛评分范围0-100,分数越高疼痛越轻;临床重要改善定义为KOOS疼痛增加≥9。
临床怎么用
- 临床实践中筛查TKA候选者的广泛性疼痛可能有用。
- 若患者并发广泛性疼痛诊断,对手术结果的期望可能需要降低。
局限性
- 男性样本中广泛性疼痛例数少,男性结果不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: When conservative treatments do not work, TKA may be the best option for patients with knee osteoarthritis, although a relatively large proportion of individuals do not have clinically important improvement after TKA. Evidence also suggests that women are less likely to benefit from TKA than men, but the reasons are unclear. Widespread pain disproportionately affects women and has been associated with worse outcomes after joint arthroplasty, yet it is unknown if the effect of widespread pain on TKA outcomes differs by patient gender. QUESTIONS/PURPOSES: (1) Does the association between widespread pain and no clinically important improvement in osteoarthritis-related pain and disability 2 years after TKA differ between men and women? (2) Does the use of pain medications 2 years after TKA differ between those with widespread pain and those without widespread pain before surgery? METHODS: Osteoarthritis Initiative (https://nda.nih.gov/oai/) study participants were followed annually from March 2005 until October 2015. Participants who underwent TKA up to the 7-year follow-up visit with pain/disability assessment at the protocol-planned visit before TKA and at the second planned annual visit after surgery were included in the analysis. Among 4796 study participants, 391 had a confirmed TKA, including 315 with pain/disability assessment at the protocol-planned visit before TKA. Overall, 95% of participants (298) had the required follow-up assessment; 5% (17) did not have follow-up data. Widespread pain was defined based on the modified American College of Rheumatology criteria. Symptoms were assessed using the WOMAC pain (range 0 to 20; higher score, more pain) and disability (range 0 to 68; higher score, more disability) scores, and the Knee Injury and Osteoarthritis Outcome Score for pain (range 0 to 100; higher score, less pain). Improvements in pain and disability were classified based on improvement from established clinically important differences (decrease in WOMAC pain ≥ 1.5; decrease in WOMAC disability ≥ 6.0; increase in Knee Injury and Osteoarthritis Outcome Score for pain ≥ 9). At baseline, more women presented with widespread pain than men (45% [84 of 184] versus 32% [36 of 114]). Probability and the relative risk (RR) of no clinically important improvement were estimated using a logistic regression analysis in which participants with widespread pain and those without were compared. The analyses were done for men and women separately, then adjusted for depression and baseline outcome scores. RESULTS: Among women, preoperative widespread pain was associated with an increased risk of no clinically important improvement 2 years after TKA, based on WOMAC pain scores (13.5% versus 4.6%; RR 2.93 [95% CI 1.18 to 7.30]; p = 0.02) and the Knee Injury and Osteoarthritis Outcome Score for pain (16.5% versus 4.9%; RR 3.39 [95% CI 1.34 to 8.59]; p = 0.02). Given the lower and upper limits of the confidence intervals, our data are compatible with a broad range of disparate associations between widespread pain and lack of clinically important improvement in WOMAC pain scores (RR 0.77 [95% CI 0.22 to 2.70]; p = 0.68) and the Knee Injury and Osteoarthritis Outcome Score for pain (RR 1.37 [95% CI 0.47 to 4.00]; p = 0.57) among men, as well as clinically important improvement in WOMAC disability scores among men (RR 0.72 [95% CI 0.20 to 2.55]; p = 0.61) and women (RR 1.98 [95% CI 0.92 to 4.26]; p = 0.08). Participants presenting with widespread pain before TKA were more likely than those without widespread pain to use medication for symptoms of knee osteoarthritis most days for at least 1 month 2 years after TKA (51% [61 of 120] versus 32% [57 of 178]; mean difference, 18.8 [95% CI 7.3 to 30.1]; p < 0.01). CONCLUSIONS: Widespread pain before TKA was associated with an increased risk of no clinically important improvement in knee pain 2 years postoperatively among women. Because of the small number of men with widespread pain in the sample, the results for men were inconclusive. In clinical practice, screening TKA candidates for widespread pain may be useful, and expectations of surgical outcomes may need to be tempered if patients have a concurrent diagnosis of widespread pain. Future studies should include more men with widespread pain and investigate if treatment of widespread pain before or concurrent with TKA surgery may improve surgical outcomes. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Vina ER, Ran D, Ashbeck EL, et al. Widespread Pain Is Associated with Increased Risk of No Clinical Improvement After TKA in Women. Clin Orthop Relat Res. 2020. PMID: 31633588. doi:10.1097/CORR.0000000000001001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。